Havana, Wednesday 29 de March de 2017 08:46 pm
Cuba has graduated over 37,000 Health technology specialists

Cuba has graduated over 37,000 Health technology specialists

Cuba has graduated about 37,000 young people in the three training models through which Health Technology has transited, said today in this city Antonio Humberto Rodríguez, Dean of the Faculty of Health Technology.

Cuba to show advances in health technology

Cuba to show advances in health technology

Cuban electro-medicine and the recovery of medical technology is one of the topics to be discussed at the 3rd International Convention on Health Technology, which will start today at the Havana Convention Center.

Over 4,500 Cubans get minimal access surgery in 2016

Over 4,500 Cubans get minimal access surgery in 2016

The National Center for Minimal Access Surgery (CNCMA by its Spanish acronym) first in Cuba of this branch of medicine, made more than 4,500 such surgical procedures in 2016, with very good results, announced the director of that institution.

Cuban vaccine against lung cancer goes to clinical trial at primary health care level

With nearly 200 patients, a clinical trial of the drug Cimavax EGF against lung cancer in primary health care (PHC) is being developed in Cuba to evaluate other parameters in order to increase the effectiveness of the first vaccine of its type registered in the world.

World Health Day Dedicated to Depression

World Health Day Dedicated to Depression

World Health Day will be dedicated this year to depression currently affecting 300 million people in the world.

Havana´s Med School to attend Health Technology meeting

The University of Medical Sciences of Havana (UCMH) and the Faculty of Health Technology convene the Third International Convention on Technology and Health, which will be held from 27 to 31 this month in Havana.

US Nobel Laureate is new Corresponding Member of the Cuban Academy of Sciences

US Nobel Laureate is new Corresponding Member of the Cuban Academy of Sciences

Dr. Peter Courtland Agre, US biologist and university professor who was awarded the 2003 Nobel Prize in Chemistry, is the new Corresponding Member of the Cuban Academy of Sciences (ACC by its Spanish acronym).

Prevention: Main antidote to avoid kidney diseases

Specialists say that kidney diseases can be prevented with education, knowledge, and a healthy lifestyle including an adequate nutrition and exercise.

Cuban Scientific Centers Praise Work of Indio Hatuey Station

Cuban scientific centers headed by the Ministry of Higher Education (MES) recognized on Wednesday the work of the Indio Hatuey Station located in Matanzas province for its contribution to the development of science, technology and innovation for the last 55 years.

Cuba to start clinical trials on drug against renal cancer

Cuba to start clinical trials on drug against renal cancer

A clinical trial with Heberferon will begin this year in Cuba in about 300 patients with renal carcinoma, announced Dr. Iraldo Bello, expert who developed the product at the Center for Genetic Engineering and Biotechnology (CIGB by its Spanish acronym).

Twenty Cubans undergo deep brain stimulation to fight Parkinson

Twenty Cubans undergo deep brain stimulation to fight Parkinson

Twenty Cuban patients with Parkinson's disease underwent deep brain stimulation surgery, since this type of medical intervention was resumed in November 2016 at Lucía Íñiguez Hospital, in the Cuban city of Holguín.

Use of Cuban Drug against Skin Cancer to be extended in the Country

Use of Cuban Drug against Skin Cancer to be extended in the Country

Heberferon, the new Cuban drug for the treatment of skin cancer obtained from biotechnological formulations, has been applied to some 800 patients in the country, the product researcher announced.

Cuban HIV vaccine´s clinical trial is underway

Cuban HIV vaccine´s clinical trial is underway

A therapeutic vaccine aimed at reducing the viral load of patients with Human Immunodeficiency Virus (HIV), which has an impact on the quality of life of patients, is currently in phase one of the clinical trial, in which its safety is studied.

Find Us:

our agency

We have over 130 experenced news professionals in 17 offices that give coverage to the entire national territory. (See more) 

Advertising